Parataxis Holdings Launches BTC Reserve Management Discussion in the South Korean Market
Parataxis Holdings is preparing to introduce a dedicated BTC reserve company for the South Korean market. This move is driven by the reverse merger strategy with the publicly listed biotech company Bridge Biotherapeutics in South Korea. This event opens a new wave in integrating cryptocurrency into local corporate financial strategies.
Reverse Merger Strategy with Bridge Biotherapeutics
Parataxis has completed a reverse merger with Bridge Biotherapeutics, valued at 25 million South Korean won (~18.5 million USD). After the merger, the new company will operate under the name Parataxis Korea, becoming a platform to promote BTC reserve funds in South Korea. This transaction opens up direct access to BTC for South Korean businesses, while enhancing risk governance and tight capital management.
BTC Reserve Fund Campaign Reinvigorated
Inspired by the BTC treasury strategic trends emerging in the United States and Japan, Parataxis aims to promote the acceptance of cryptocurrency among South Korean businesses. This move reflects a global trend of increasing interest among institutional investors in building BTC reserves, even on a smaller scale. However, the main goal remains to ensure reasonable corporate governance and disciplined reserve management.
Parataxis Transitions to Maximalist BTC Strategy
As a member of Parataxis Capital, a company with a diversified strategy, Parataxis Holdings has clearly defined a direction for BTC. This reflects a strong shift from old Web3 projects such as NFTs and governance platforms to BTC accumulation tactics as part of a long-term strategy. Meanwhile, the company maintains its position in small funding rounds, focusing on maximizing Bitcoin value.
Bridge Biotherapeutics Before Being Acquired and Cryptocurrency Trading
Bridge Biotherapeutics has experienced a stock price drop of more than 76% since April, due to a significant revenue decline from several flagship drugs. The publicly listed biotech company since 2019 develops specific, high-risk pharmacological regimens. However, the shift towards a BTC reserve strategy has led to signs of a temporary stock price recovery, although it has yet to reach previous highs. This initiative emphasizes that building a BTC reserve does not guarantee sustainable growth for the stock, especially in the short term.
Parataxis lowers Bridge Biotherapeutics' stock price, aiming for recovery by building a BTC reserve fund for the South Korean market. | Source: Google Finance
In this context, institutional investors are beginning to recognize the benefits of BTC accumulation, particularly through reverse merger strategies and equity financing. These biotech companies are experimenting with transformation models aimed at enhancing long-term value and differentiating their financial strategies.
Source: https://tintucbitcoin.com/parataxis-korea-giu-chien-luoc-metaplanet/
Thank you for reading this article!
Please Like, Comment, and Follow TinTucBitcoin to stay updated with the latest news in the cryptocurrency market and not miss any important information!
